Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,860.00p
   
  • Change Today:
    -8.00p
  • 52 Week High: 2,568.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 829,710
  • Market Cap: £1,228.21m
  • RiskGrade: 128

Genus FY profit nudges up but revenue slips on lower bovine volumes

By Michele Maatouk

Date: Thursday 08 Sep 2016

LONDON (ShareCast) - (ShareCast News) - FTSE 250 animal genetics company Genus posted an increase in pre-tax profit for the year to the end of June despite a small drop in revenue.
Adjusted pre-tax profit was up 7% to £49.7m, driven by strong performances in Genus PIC and Genus Asia, particularly China.

Statutory pre-tax profit was 5% higher at £60.9m, which included a pension-related exceptional credit of £44.2m and a reduction in the value of biological assets.

However, revenue at the group was down 3% to £388.3m on the back of lower bovine volumes in tough dairy markets and lower porcine by-product and up-front sales.

Chief executive Karim Bitar said: "Genus performed well overall in 2016 with another year of double digit constant currency profit growth and substantial strategic progress in our R&D endeavours in addition to growth in key markets such as China.

"To pursue our long-term growth objectives, we plan to increase R&D investment in FY17 and therefore expect broadly stable constant currency results, however exchange rates should provide a benefit to the reported numbers. Overall we expect to perform in line with market expectations. We are confident in the future of the business and are proposing a 10% increase in the dividend."

The company proposed a total dividend for the year of 21.4p per share, up from 19.5p in 2015.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,860.00p
Change Today -8.00p
% Change -0.43 %
52 Week High 2,568.00
52 Week Low 1,637.00
Volume 829,710
Shares Issued 66.03m
Market Cap £1,228.21m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
56.88% below the market average56.88% below the market average56.88% below the market average56.88% below the market average56.88% below the market average
7.41% above the sector average7.41% above the sector average7.41% above the sector average7.41% above the sector average7.41% above the sector average
Income
86.38% below the market average86.38% below the market average86.38% below the market average86.38% below the market average86.38% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 14-May-2024

Time Volume / Share Price
16:35 26,212 @ 1,860.00p
16:35 52 @ 1,860.00p
16:35 364 @ 1,860.00p
16:35 364 @ 1,860.00p
16:35 62 @ 1,860.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page